Climb Bio (CLYM) Cash & Current Investments (2020 - 2026)
Climb Bio's Cash & Current Investments was $183.12 million in Q2 2026, up 116.2% from $84.7 million a year earlier and up 67.1% from the prior quarter.
Powered by 
Analysis
Climb Bio (CLYM) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Climb Bio came in at $101.08 million, down 33.0% from FY2024.
- Cash & Current Investments shows a five-year compound annual growth rate of 37.6% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $150.92 million in FY2024 (+41.3%), $106.8 million in FY2023 (-13.6%), $123.57 million in FY2022 (-9.5%) and $136.48 million in FY2021 (+566.2%).
- The Q2 2026 figure marks the highest quarterly Cash & Current Investments since Q3 2024.
- Compared with a year earlier, Cash & Current Investments was higher in four of the last eight quarters, with growth averaging 11.6%.
- The best year-over-year quarter for Cash & Current Investments over five years was Q4 2021 (growth of 566.2%); the worst was Q2 2025 (a decline of 62.0%).
- Per Business Quant data, CLYM's Cash & Current Investments in the three quarters before Q2 2026 was $109.56 million (Q1 2026), $101.08 million (Q4 2025) and $86.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Climb Bio | 777.53 Mn | 296.87 Mn | - | 183.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 183.12 Mn |
| Mar 31, 2026 | 109.56 Mn |
| Dec 31, 2025 | 101.08 Mn |
| Sep 30, 2025 | 86.90 Mn |
| Jun 30, 2025 | 84.70 Mn |
| Mar 31, 2025 | 98.06 Mn |
| Dec 31, 2024 | 150.92 Mn |
| Sep 30, 2024 | 193.35 Mn |
| Jun 30, 2024 | 223.14 Mn |
| Mar 31, 2024 | 105.03 Mn |
| Dec 31, 2023 | 106.80 Mn |
| Sep 30, 2023 | 107.43 Mn |
| Jun 30, 2023 | 102.63 Mn |
| Mar 31, 2023 | 109.37 Mn |
| Dec 31, 2022 | 123.57 Mn |
| Sep 30, 2022 | 122.62 Mn |
| Jun 30, 2022 | 122.95 Mn |
| Mar 31, 2022 | 123.94 Mn |
| Dec 31, 2021 | 136.48 Mn |
| Sep 30, 2021 | 146.02 Mn |
API Access
Climb Bio Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CLYM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "CLYM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CLYM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();